Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selection of cell source for ligament tissue engineering.

Zigang Ge1, James Cho Hong Goh, Eng Hin Lee

  • 1Department of Orthopaedic Surgery, National University of Singapore.

Cell Transplantation
|December 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SMSC-EVs restore chondrocyte function through S1PR1-mTORC2-mediated mitochondrial fusion and GPS2-HDAC1-driven epigenetic regulation.

Osteoarthritis and cartilage·2026
Same author

Enhanced anticancer efficacy of α-lipoic acid-loaded TPGS micelles: Synthesis, characterization, and evaluation in a 4T1 breast cancer model.

BioImpacts : BI·2026
Same author

Ultrasensitive Cascade Enzyme Immunoassay Electrochemical Microfluidic Chip for Early Screening of Prostate Cancer.

ACS sensors·2026
Same author

NsPEFs-enriched ADSCs-EVs alleviate osteoarthritis via RSPO3-mediated dual pro-chondrogenic and pro-M2 macrophage properties.

Bioactive materials·2026
Same author

Understanding the molecular basis of mesenchymal stem cell stemness: implications for clinical applications.

Cell death & disease·2025
Same author

Fostering Scientific Courage, Rigor, Innovation, and Collaboration: <i>JBJS Open Access:</i> Methods, Pilots, and Protocols.

JB & JS open access·2025
Same journal

Tissue repair and donor-dependent immune responses after allogeneic skeletal muscle-derived cell sheet transplantation in a rat gastric ulcer model.

Cell transplantation·2026
Same journal

Short-course blinatumomab as a bridge-to-transplantation improves the survival of Ph-negative MRD-positive B-ALL.

Cell transplantation·2026
Same journal

Transplantation of human umbilical mesenchymal stromal cells attenuates heart failure progression in a rat model.

Cell transplantation·2026
Same journal

Three-dimensionally printed mesoporous bioactive glass for craniomaxillofacial bone regeneration: Material evolution, functional mechanisms, and clinical translation.

Cell transplantation·2026
Same journal

Hotspots and trends in stem cell therapy for ligament injuries: A bibliometric analysis (2001-2025).

Cell transplantation·2026
Same journal

Amniotic epithelial cells enhance islet engraftment by suppressing early inflammation in intraportal transplantation.

Cell transplantation·2026
See all related articles

Mesenchymal stem cells (MSCs) show greater proliferation and collagen production than anterior cruciate ligament (ACL) and medial collateral ligament (MCL) fibroblasts. MSCs are a promising cell source for ACL tissue engineering.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Orthopedic Surgery

Background:

  • Optimizing cell sources is crucial for enhancing tissue-engineered constructs' function and structure.
  • Limited knowledge exists regarding the ideal cell source for ligament tissue engineering.

Purpose of the Study:

  • To identify the optimal cell source for anterior cruciate ligament (ACL) tissue engineering.
  • To compare bone marrow mesenchymal stem cells (MSCs) with anterior cruciate ligament (ACL) and medial collateral ligament (MCL) fibroblasts.

Main Methods:

  • Assessed proliferation rates, collagen excretion, and expression of collagen types I, II, III, and alpha-smooth muscle actin.
  • Utilized green fluorescent protein (GFP)-transfected MSCs for in vivo tracking within knee joints.

Related Experiment Videos

Main Results:

  • MSCs, ACL, and MCL fibroblasts expressed collagen types I and III and alpha-smooth muscle actin, but not collagen type II.
  • MSCs exhibited significantly higher proliferation rates and collagen excretion compared to ACL and MCL fibroblasts (p < 0.05).
  • MSCs demonstrated survival in knee joints for at least 6 weeks.

Conclusions:

  • Mesenchymal stem cells (MSCs) represent a potentially superior cell source for anterior cruciate ligament (ACL) tissue engineering compared to ACL and MCL fibroblasts.
  • The findings support the use of MSCs in developing more effective ACL tissue regeneration strategies.